However, if we distinguish the PD1+ EVs coming from non-responders compared to responders we observed a statistically significant increase in PD1+ EVs in the first group evident both if these were released from melanoma cells and from analysed immune cells (Supplemental Fig. S1E). Here, PDCD1 is linked to melanoma.